These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 6684226

  • 21. [Anti-acetylcholine and anti-receptor antibodies in myasthenia].
    Lebrun-Grandie P, Souan ML, Geffard M, Dartigues JF, Mauricet B, Orgogozo JM.
    Presse Med; 1987 Oct 03; 16(32):1577-80. PubMed ID: 2958833
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG).
    Graus YM, van Breda Vriesman PJ, de Baets MH.
    Clin Exp Immunol; 1993 Jun 03; 92(3):506-13. PubMed ID: 8513583
    [Abstract] [Full Text] [Related]

  • 27. Both binding and blocking antibodies correlate with disease severity in myasthenia gravis.
    Kang SY, Oh JH, Song SK, Lee JS, Choi JC, Kang JH.
    Neurol Sci; 2015 Jul 03; 36(7):1167-71. PubMed ID: 25964166
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A solid-phase enzyme immunoassay for anti-acetylcholine receptor antibody in myasthenia gravis patients.
    Kobayashi N, Sugita H, Terada E, Ghoda A, Okudaira H, Ogita T, Miyamoto T.
    J Immunol Methods; 1984 Oct 26; 73(2):267-72. PubMed ID: 6386990
    [Abstract] [Full Text] [Related]

  • 31. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J, Maida EM, Mamoli B, Mayr N.
    Wien Med Wochenschr; 1986 Jul 15; 136(13):329-32. PubMed ID: 3765651
    [Abstract] [Full Text] [Related]

  • 32. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S, Morel E, Gaud C, Raimond F, Le Brigand H, Bach JF.
    Neurology; 1984 Jan 15; 34(1):66-71. PubMed ID: 6228745
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T, Beyth Y, Abramsky O.
    Proc Natl Acad Sci U S A; 1980 Jun 15; 77(6):3635-9. PubMed ID: 6158053
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML, Geffard M.
    Neurosci Lett; 1986 Aug 04; 68(3):282-7. PubMed ID: 2427976
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.